FDA Inspection 1279428 — SOFIE Co.

SOFIE Co. — FEI 3006246010

The FDA completed an inspection of SOFIE Co. on August 7, 2025 in Gilroy, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gilroy, CA (United States)

Citations

IDCFRDescription
1772321 CFR 212.10Personnel not qualified
1788221 CFR 212.70(d)(2)Data and documentation review
2137321 CFR 212.30(b)Equipment procedures